394 related articles for article (PubMed ID: 36674537)
1. Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis.
Paroli M; Caccavale R; Paroli MP; Spadea L; Accapezzato D
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674537
[TBL] [Abstract][Full Text] [Related]
2. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
Braun J; Kiltz U; Baraliakos X
Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
[TBL] [Abstract][Full Text] [Related]
3. Treatment of axial spondyloarthritis: an update.
Danve A; Deodhar A
Nat Rev Rheumatol; 2022 Apr; 18(4):205-216. PubMed ID: 35273385
[TBL] [Abstract][Full Text] [Related]
4. The role of upadacitinib for the treatment of axial spondyloarthritis.
George N; Liew JW; Dubreuil M
Immunotherapy; 2023 Oct; 15(15):1227-1237. PubMed ID: 37675498
[TBL] [Abstract][Full Text] [Related]
5. Advances in pharmacotherapies for axial spondyloarthritis.
Toussirot E
Expert Opin Pharmacother; 2023; 24(13):1439-1448. PubMed ID: 37318776
[TBL] [Abstract][Full Text] [Related]
6. News in the treatment of axial spondyloarthritis.
Žurek M; Horák P
Vnitr Lek; 2022; 68(5):279-284. PubMed ID: 36283817
[TBL] [Abstract][Full Text] [Related]
7. New developments in ankylosing spondylitis-status in 2021.
Klavdianou K; Tsiami S; Baraliakos X
Rheumatology (Oxford); 2021 Dec; 60(Suppl 6):vi29-vi37. PubMed ID: 34951921
[TBL] [Abstract][Full Text] [Related]
8. Effects of disease-modifying anti-rheumatic drugs on sacroiliac MRI score in axial spondyloarthritis: a systematic review and meta-analysis.
Hansmaennel A; Fakih O; Gerazime A; Prati C; Chouk M; Wendling D; Verhoeven F
Clin Rheumatol; 2024 Mar; 43(3):1045-1052. PubMed ID: 38158505
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis.
Braun J; Kiltz U; Baraliakos X
Expert Opin Biol Ther; 2023 Feb; 23(2):195-206. PubMed ID: 36511882
[TBL] [Abstract][Full Text] [Related]
10. JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials.
Keeling S; Maksymowych WP
Expert Rev Clin Immunol; 2021 Jul; 17(7):701-715. PubMed ID: 33944642
[TBL] [Abstract][Full Text] [Related]
11. Axial Spondyloarthritis: Evolving concepts regarding the disease's diagnosis and treatment.
Drosos AA; Venetsanopoulou AI; Voulgari PV
Eur J Intern Med; 2023 Nov; 117():21-27. PubMed ID: 37414646
[TBL] [Abstract][Full Text] [Related]
12. Pain in axial spondyloarthritis: role of the JAK/STAT pathway.
Selmi C; Chimenti MS; Novelli L; Parikh BK; Morello F; de Vlam K; Ciccia F
Front Immunol; 2024; 15():1341981. PubMed ID: 38464510
[TBL] [Abstract][Full Text] [Related]
13. Novel therapies in axial spondyloarthritis.
Bittar M; Mease P
Best Pract Res Clin Rheumatol; 2022 Dec; 36(4):101811. PubMed ID: 36566165
[TBL] [Abstract][Full Text] [Related]
14. Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis.
Mease P
Curr Rheumatol Rep; 2019 Jun; 21(7):35. PubMed ID: 31172311
[TBL] [Abstract][Full Text] [Related]
15. No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors.
Zhang H; Jiang HL; Dai SM
Front Immunol; 2022; 13():818413. PubMed ID: 35222393
[TBL] [Abstract][Full Text] [Related]
16. JAK Inhibitors for the Treatment of Axial Spondyloarthritis.
Klavdianou K; Papagoras C; Baraliakos X
Mediterr J Rheumatol; 2023 Jun; 34(2):129-138. PubMed ID: 37654636
[TBL] [Abstract][Full Text] [Related]
17. The Future of Axial Spondyloathritis Treatment.
Maguire S; Sengupta R; O'Shea F
Rheum Dis Clin North Am; 2020 May; 46(2):357-365. PubMed ID: 32340707
[TBL] [Abstract][Full Text] [Related]
18. Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies.
Hammitzsch A; Lorenz G; Moog P
Front Immunol; 2020; 11():591176. PubMed ID: 33193430
[TBL] [Abstract][Full Text] [Related]
19. A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition.
McInnes IB; Szekanecz Z; McGonagle D; Maksymowych WP; Pfeil A; Lippe R; Song IH; Lertratanakul A; Sornasse T; Biljan A; Deodhar A
Rheumatology (Oxford); 2022 May; 61(5):1783-1794. PubMed ID: 34668515
[TBL] [Abstract][Full Text] [Related]
20. JAK Inhibitors for Axial Spondyloarthritis: What does the Future Hold?
Akkoc N; Khan MA
Curr Rheumatol Rep; 2021 Apr; 23(6):34. PubMed ID: 33909185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
